Intestinal immune homeostasis and microbiome structure play a critical role in the
pathogenesis and progress of inflammatory bowel disease (IBD), whereas IBD treatment …

Mesenchymal stem cells (MSCs) are an attractive candidate for the treatment of
inflammatory bowel disease (IBD), but their poor delivery rate to an inflamed colon is a major …

Background Due to oral nano-delivery systems for the treatment of inflammatory bowel
disease (IBD) are often failed to accumulated to the colonic site and could not achieve …

Hydrogel microspheres with probiotic‐loaded therapy have been considered an effective
and safe strategy for treating inflammatory bowel disease (IBD). However, the low survival …

The effective delivery and colonization of probiotics are recommended for therapeutic
interventions during colitis, the efficacy of which is hampered by abnormally colonized …

The active stages of intestinal inflammation and the pathogenesis of ulcerative colitis are
associated with superficial mucosal damage and intermittent wounding that leads to …

Despite the progress in the therapy of ulcerative colitis (UC), long-lasting UC remission can
hardly be achieved in the majority of UC patients. The key pathological characteristics of UC …

Ulcerative colitis (UC) as an important type of inflammatory bowel disease is a chronic
disease characterized by intestinal dyshomeostasis. The UC treatment is challenged by the …

Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease that features
colonic epithelial barrier dysfunction and gut dysbiosis. Preclinical studies demonstrated that …

Inflammatory bowel disease (IBD) is characterized by the high level of reactive oxygen
species (ROS) and highly dysfunctional intestinal flora. Here, a stimulation-responsive …